Beam Therapeutics Inc. BEAM
Set alert
25.87 USD -1.36 -4.99%
At close · Nov 2
25.87 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
25.79 Day range 27.67
20.23 52-week range 38.26
- YTD
- -6.67%
- 1 year
- +3.44%
- Open
- 27.45
- Prev close
- 27.23
- Mkt cap
- 2.67B
- Vol
- 1.44M
- Avg vol
- 1.84M
- EPS
- -0.68
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 25.79
- High
- 27.67
- Forward P/E
- -5.45
- Beta
- 2.22
- Short ratio
- 13.87
- Inst. own
- 107.81%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 25.93
- 200-d avg
- 28.14
- 1y target
- 49.38
3M chart
Events in this range
- Aug 4, 2026Earnings: -1.18; estimate -1.11; surprise -6.31%
- Aug 25, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Sep 9, 2026Rating: Wedbush · Outperform → Outperform
- Oct 14, 2026Rating: Wedbush · Outperform → Outperform
- Oct 15, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Oct 28, 2026Rating: Wedbush · Outperform → Outperform
- Oct 29, 2026Rating: Canaccord Genuity · Buy → Buy
Signals (15)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| SMA: Bullish | Oct 27, 2026 | 6 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
Ownership
Held by insiders 1.20%
Held by institutions 107.81%
Float held by institutions 109.12%
Institutions 396
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 12.21% | 12,609,002 | 326.19M | Jun 29, 2026 |
| Farallon Capital Management LLC | 9.91% | 10,236,396 | 264.82M | Jun 29, 2026 |
| ARK Investment Management, LLC | 9.91% | 10,234,862 | 264.78M | Jun 29, 2026 |
| Blackrock Inc. | 8.71% | 8,997,542 | 232.77M | Jun 29, 2026 |
| State Street Corporation | 5.64% | 5,827,122 | 150.75M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.76% | 4,921,259 | 127.31M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK ETF Trust-ARK Innovation ETF | 7.33% | 7,575,673 | 195.98M | Sep 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 3.35% | 3,457,347 | 89.44M | Aug 30, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.33% | 3,441,420 | 89.03M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 3,273,307 | 84.68M | Jun 29, 2026 |
| ARK ETF Trust-ARK Genomic Revolution ETF | 2.61% | 2,696,956 | 69.77M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.49% | 2,569,276 | 66.47M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BELLON CHRISTINE | Officer | Sale | Mar 31, 2026 | 109,711 |
| CAVANAGH BETHANY J | Officer and Treasurer | Sale | Mar 31, 2026 | 51,171 |
| CIARAMELLA GIUSEPPE | President | Conversion of Exercise of derivative security | Jun 16, 2026 | 253,911 |
| EMANY SRAVAN KUMAR | Chief Financial Officer | Stock Award(Grant) | Mar 30, 2026 | 105,456 |
| EVANS JOHN M. | Chief Executive Officer | Sale | Jun 29, 2026 | 1,150,200 |
| FMR, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 25, 2026 | 0 |
Held by funds
129 US ETFs and mutual funds hold BEAM · largest positions